In a separate analysis (data not shown), we noted that patients with abnormal chromosome genomic array testing had higher blast percentages by flow cytometry, but this association did not reach statistical significance ( P = 0.07).
← all excerpts
Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome.
1
0.0700
0.0700